Replies to post #21796 on Cannabix Technologies Inc (BLOZF)

[Carthnel]

Awesome again on keeping the count ! Patiently awaiting the news announcement of an awarded patent, too

[FreezeThese]

Just had a chance to read this ... initial patent filing being challenged?

As of June 30, 2017, and December 21, 2017 the Company has received office actions and comments from the US Patent Office. As it is entitled to do with all patent applications, the Company is currently preparing to file a response to overcome objections raised in December 2017 to the current claims of the application, while also preparing a continuation application to distinguish the Company’s technology from prior art patents. The Company is required to submit its arguments and claim amendments no later than June 2018. There is no assurance that a final patent will be accepted and issued by regulatory authorities.


Where are they flying?

... and travel related expenses of $3,917

I genuinely lol'd here

and investor communications fees may increase slightly

uhh ... what economy?

The Company may encounter difficulty sourcing future financing in light of the recent economic downturn.

Here I thought we were depressed sheesh, lighten up fellas

Due to the recovery from the global financial crisis, the Company may find it increasingly difficult to raise the funds required to continue the Company’s operations. Share prices have undergone significant decreases and any issuance of the Company’s equity securities in the near future may result in substantial dilution to the Company’s existing shareholders.

Glad Kal's Family is still getting there's ... what're they consulted for? Wallpaper design? Employee of the month? Designated parking spots?

During the period ended January 31, 2018, the Company incurred consulting fees of $30,500 (2017 - $22,500) to the Chief Executive Officer of the Company.

(c) During the period ended January 31, 2018, the Company incurred consulting fees of $26,000 (2017 - $18,000) to the Chief Financial Officer of the Company.

(d) During the period ended January 31, 2018, the Company incurred consulting fees of $42,000 (2017 - $42,000) to a company controlled by the President of the Company.

(e) During the period ended January 31, 2018, the Company incurred research and development costs of $26,000 (2017 - $18,000) to a director of the Company.